Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2023

Stagg J, Golden E, Wennerberg E, Demaria S. The interplay between the DNA damage response and ectonucleotidases modulates tumor response to therapy. Sci Immunol. 2023;8(85):eabq3015.

Kubiak J, Morgan A, Kirmaier A, Arnaout R, Riedel S. Universal PCR for bacteria, mycobacteria, and fungi: a 10-year retrospective review of clinical indications and patient outcomes. J Clin Microbiol. 2023;61(12):e0095223.

Petersen J, Du W, Adkisson C, Gravekamp C, Oktay MH, Condeelis J, et al. Stabilized Window for Intravital Imaging of the Murine Pancreas. J Vis Exp. 2023;(200).

Gonzalez AA, Olsen EL, Killeen SZ, Blair RV, Seshan SV, Jaimes EA, et al. Elevated soluble urokinase plasminogen activator receptor is associated with renal dysfunction in a Chlorocebus atheiops COVID-19 model. J Med Primatol. 2023;52(2):131-134.

Salinas T, Li C, Snopkowski C, Stryjniak G, Shankaranarayanan D, Albakry S, et al. Urinary cell mRNA profiling of kidney allograft recipients: Development of a portable protocol for noninvasive diagnosis of T cell mediated rejection and BK virus nephropathy. J Immunol Methods. 2023;512:113402.

Munoz-Zuluaga C, Zhao Z, Wang F, Greenblatt MB, Yang HS. Assessing the Accuracy and Clinical Utility of ChatGPT in Laboratory Medicine. Clin Chem. 2023;69(8):939-940.

Bajema IM, Balow JE, Haas M, Jayne D, Lightstone L, Rovin BH, et al. Update on scoring and providing evidence basis for assessing pathology in lupus nephritis. Kidney Int. 2023;103(5):813-816.

Bharati J, Bijol V, Salvatore S, Jhaveri KD, Sharma P. The Case | A benign reason behind a malignant finding. Kidney Int. 2023;103(2):433-434.

Guadix SW, Garman TS, Gundlach C, Pisapia DJ, Souweidane MM. Durability of an endoscopic management strategy for recurrent choroid plexus carcinoma with a comprehensive molecular characterization: illustrative case. J Neurosurg Case Lessons. 2023;5(10).

Nguyen-Dien GT, Kozul K-, Cui Y, Townsend B, Kulkarni PG, Ooi SS, et al. FBXL4 suppresses mitophagy by restricting the accumulation of NIX and BNIP3 mitophagy receptors. EMBO J. 2023;42(13):e112767.